ADHD Drug Shortage in the US

The shortage of attention deficit hyperactivity disorder drugs continues to remain a serious problem in the United States

The non-availability of ingredients and the tight controls enforced by the Drug Enforcement Administration means that the shortage of attention deficit hyperactivity disorder drugs continues to remain a serious problem in the United States.

The ADHD drugs are powerful stimulants and the drugs are popular among college students who use them to stay up all night and improve test scores. The DEA tightly regulates the manufacturing of such drugs in order to make sure than there are no stockpiles created which can then be used in an inappropriate manner.

Attention Deficit Hyperactivity Disorder-Causes-Symptoms-Diagnosis-Treatment-FAQ
Attention Deficit Hyperactivity Disorder (ADHD) is a neurobiological disorder that affects normal behavior and impairs the ability to concentrate.

However the DEA’s tight regulations mean that the pharmacists are unable to acquire sufficient amounts of active pharmaceutical ingredient (API) required to make the drugs. The rising demand means that a number of pharmacies are unable to fill out the prescriptions.

Stating that pharmacies will once again experience shortages this year, the chief executive of Children and Adults with Attention Deficit/Hyperactivity Disorder (CHADD), Ruth Hughes said, “I am very concerned about the future. No one seems to have much inventory to get us through the months ahead. There are real major life impacts for people not having access to medication. Someone needs to own this problem and take the initiative to fix it.”

Exposure to Smoking in Prenatal Stage Increases ADHD Risk in Children
Some expectant mothers who smoke during pregnancy may be exposing their baby to the risk of the attention deficit/hyperactivity disorder (ADHD), according to a study

Source-Medindia

ADHD Medications may Not Increase the Risks of Serious Cardiovascular Events in Adults
Use of ADHD medications does not increase the risk of heart attack, sudden cardiac death or stroke in adults.

FDA Certifies Novel ADHD Drug
Washington - The FDA has permitted the use of a new drug to treat attention deficit hyperactivity disorder. The drug known as Vyvanse, is manufactured by Shire PLC.